Company: KITTW
Filing Date: 2025-10-24
Form Type: 424B3
Source: 0001849820-25-000253
Chunk: 10

Company: Nauticus Robotics, Inc.
Filing Date: 2025-10-24
Form: 424B3
Chunk 10
---
880 shares of common stock issuable upon exercise of stock options outstanding under our equity incentive plans, with a weighted-average exercise price of $652.59 per share;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 •60,602 shares of common stock issuable upon exercise of outstanding warrants, with a weighted average exercise price of $83.25 per share;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 •233,062 shares of common stock issuable upon conversion of outstanding convertible debentures.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 •630,225 shares of common stock issuable upon conversion of outstanding convertible term loans;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 •2,308,536 shares of common stock issuable upon conversion of outstanding preferred equity; and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 •143,133 shares of common stock available for future issuance under our 2022 Omnibus Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Plan of Distribution                                          |     | “At the market offering” that may be made from time to time through or to Wainwright, as sales agent or principal. See “Plan of Distribution” in this prospectus supplement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

<div align='center'>S-6</div>

| Use of Proceeds                  |     | We intend to use the net proceeds, if any, from this offering for working capital and general corporate purposes. See “Use of Proceeds” beginning on page S-10 of the prospectus supplement dated June 30, 2025.                                                                                                                                                                                                                                                                                                                       |
|:---------------------------------|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Risk Factors                     |     | Investing in our common stock involves significant risks. Please read the information contained in and incorporated by reference under the heading “Risk Factors” on page S-7 of this prospectus supplement and under similar headings in the other documents that are filed after the date hereof and incorporated by reference into this prospectus supplement, together with the other information included in or incorporated by reference into this prospectus supplement, before deciding whether to invest in our common stock. |
| The Nasdaq Capital Market Symbol |     | KITT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

<div align='center'>S-7</div>

### RISK FACTORS
Investing in our common stock involves significant risks. Please see the risk factors under the heading “Risk Factors” in any prospectus supplement as well as in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form